Does diet matter when treating feline diabetes mellitus?November 1, 2019Domestic cats (Felis catus) are amazing creatures that evolved from wild ancestors known to be obligate carnivores or hypercarnivores.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Zoetis, Purina, Merck team up for diabetes campaignAugust 30, 2019November is Pet Diabetes Month, and the Diabetes Pet Care Alliance is once again encouraging veterinarians to enroll their clinics in their program.
AAFP releases educational toolkit for feline diabetesMay 22, 2019Managing and treating feline diabetes mellitus can be complicated, which is why the American Association of Feline Practitioners (AAFP) is releasing a Diabetes Educational Toolkit. A digital information source, the online toolkit provides veterinarians with the most relevant diagnostic and treatment information for diabetes mellitus, which is not always easy to diagnose. Further, veterinary professionals can access and gather information quickly via navigation tabs. Users can move directly to information focusing on diagnosis, treatment, remission strategy, troubleshooting, frequently asked questions, and client resources. According to AAFP, cats with diabetes mellitus require a customized treatment plan, including frequent reassessment and adjustments. The association notes that patient goals, finances, implementation of the treatment plan, and the patient's response are all aspects of effective treatment. "We are excited to release this digital resource to the veterinary community in hopes we can help veterinary professionals in the diagnosis and treatment of their diabetic feline patients through providing easy-to-access information that can be implemented for each cat," says Apryl Steele, DVM, president of AAFP's board of directors. "The purpose is to create more informed veterinary teams, as well as cat caregivers. This Diabetes Educational Toolkit is intended to be an on-the-ground tool for veterinary professionals …
FDA approves new drug for diabetic dogsFebruary 12, 2019A new drug for managing diabetes mellitus in dogs has been approved for use in the U.S.
Henry Schein releases new online resources for Pet Diabetes Awareness MonthNovember 8, 2018Henry Schein Animal Health’s web-based pet diabetes resource center now contains a host of new and shareable assets designed to raise awareness, enhance understanding, and improve management of the disease among the veterinary community and pet parents.
New research for canine, human Type 1 diabetes holds promiseAugust 24, 2018Reversing Type 1 diabetes in dogs and humans without the use of daily insulin injections or pumps may become a reality, thanks to a collaboration between Purdue University and the Indiana University School of Medicine. In a preclinical study, researchers developed a mixture of collagen and pancreatic cells and engineered a delivery method that successfully reversed Type 1 diabetes within 24 hours and maintained insulin independence for 90 days. A clinical study in dogs with naturally occurring Type 1 diabetes in collaboration with Purdue's College of Veterinary Medicine is next. "We plan to account for differences from mouse to human by helping dogs first," said Clarissa Hernandez Stephens, first author on the work and a graduate researcher at Purdue's Weldon School of Biomedical Engineering. "This way, the dogs can inform us on how well the treatment might work in humans." Because diabetes in dogs and humans occurs the same, both potentially could benefit from the same cure: A new set of pancreatic cells to replace islets (clusters of cells) that aren't releasing insulin to monitor blood glucose levels. Islet transplantation isn't new, and it poses challenges: It requires multiple donors, it's invasive, and large numbers of transplanted …
NIH awards UF veterinarian five-year grant to study canine diabetesAugust 24, 2018Allison O'Kell, DVM, a small animal internal medicine specialist and clinical assistant professor at the University of Florida College of Veterinary Medicine, has received a Mentored Clinical Scientist Research Career Development Award from the National Institutes of Health in support of her studies relating to canine diabetes. The five-year grant, known as a K08, will support Dr. O'Kell's career and research project. "The overall goal of my research is to study the causes of diabetes in the dog," O'Kell said. "We hope that the work will benefit dogs with this disease, but also to help us better understand whether studying the disease in dogs may be a novel way to understand the disease in humans." The disease has been increasing in prevalence over time in both dogs and humans, emphasizing the importance of research to determine the underlying causes of the disease as well as methods for prevention and treatment, she added. O'Kell's primary mentor is Mark Atkinson, PhD, the American Diabetes Association Eminent Scholar for Diabetes Research and Jeffrey Keene Family Professor in the UF College of Medicine. Atkinson also directs the UF Diabetes Institute and has been investigating human Type 1 diabetes for …
Diabetes and dental diseaseAugust 16, 2018As veterinary practitioners, we see our fair share of diabetic patients who require extensive dental work. The goal with these patients is to improve their quality of life and, in some cases, improve glycemic control by removing a source of chronic infection in the form of periodontal disease. The challenge is to “do no harm” in the process. Invariably, oral surgery will set back the appetite of any patient. Lack of appetite becomes a bigger issue when a patient has diabetes and is supplemented with injectable insulin.
Florida manufacturer develops rapid animal diabetes testingMarch 20, 2018Tallahassee, Fla.-based Baycom Diagnostics has developed A1Care, a cost-effective kit for monitoring and testing for both feline and canine diabetes. Much like with humans, cases of diabetes in dogs and cats have increased steadily over recent years. According to research released by Vancouver, Wash.-based Banfield Pet Hospital, instances of dog diabetes have increased from 13.1 cases per 10,000 in 2006 to 23.6 cases per 10,000 in 2015—a 79.7 percent jump in less than 10 years. While previous tests for detecting the disease in dogs and cats have been largely expensive and time consuming, A1Care is neither, the company stated. The test allows veterinarians to mail a patient's dried blood sample to Baycom's labs; the sample is analyzed and results are returned to the clinic within two weeks—all with a fee of $49 per test. "For the vets, it is super easy to use," said Gus Ray, Baycom's CEO. "Blood, information, mail, and you're done. All of the magic happens once we get the sample." Ray developed A1Care after he was hired to conduct at-home glycated hemoglobin (A1C) testing for diabetic persons. Initially, he thought the same test could be effective when testing for the disease in …
Likarda receives $4M to expand companion animal diabetes researchSeptember 4, 2017Likarda, a regenerative medicine company for companion animals, has received $4 million in Series A funding from Werth Family Investment Associates to back the company's proprietary Kanslet insulin-producing cell clusters, which can be infused into animals with diabetes, allowing veterinarians to offer a minimally invasive and cost-effective answer to pet owners, according to the company. Microencapsulated islets (the insulin-producing cells of the body) are transplanted via injection into the belly of a diabetic dog, removing the need for twice-daily insulin injections, the company stated. The additional funding allows Likarda to scale the project to thousands of animals, and the clinical research program is expected to launch by the end of 2017. "Partnership with Werth Family Investment Associates brings both funds to advance our product line and extensive experience in successful pharmaceutical licensing of new products for both human and animal health," said Lisa Stehno-Bittel, Ph.D., Likarda president and co-founder. "[It's] exciting and transformational for both animal health in the region and the global prospect of cell-based therapies for diabetic pets."
